End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | +2.17% | -6.78% | +20.77% |
05-23 | Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing | MT |
05-10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
Evolution of the average Target Price on Zura Bio Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zura Bio Limited
Oppenheimer | |
Piper Sandler | |
Ladenburg Thalmann | |
Raymond James | |
Guggenheim | |
Chardan Research |
EPS Revisions
- Stock Market
- Equities
- ZURA Stock
- Consensus Zura Bio Limited